MedAlliance: First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR

GENEVA, Switzerland, Sept. 10, 2022 /PRNewswire/ -- An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial

Related Keywords

National Taiwan University Hospital ,T Ai Pei ,Taiwan ,Nyon ,Switzerland General ,Switzerland ,Germany ,United States ,United Kingdom ,Singapore ,Geneva ,Genè ,Taiwanese ,Richard Kenyon ,Kostenloser Wertpapierhandel ,Tzung Dau Wang ,Ma Med Alliance ,Cath Lab ,Cell Adherent Technology ,Erectile Dysfunction ,Revascularization For ,Cardiac Cath Lab ,Medalliance ,First ,Patient ,Unrolled ,Erectile ,Dysfunction ,Prospective ,Randomized ,Study ,Selution ,